Savant Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.23M	Sell	3,766 -12,825	-77%	-$4.18M	0.01%	733
2025 Q1	$4.48M	Buy	16,591 +4,853	+41%	+$1.31M	0.03%	299
2024 Q4	$2.76M	Buy	11,738 +4,291	+58%	+$1.01M	0.02%	356
2024 Q3	$2.05M	Buy	+7,447	New	+$2.05M	0.02%	419